SAN DIEGO, May 2, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced today that management will presentat the 2017 Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 16th, at 4:20 PM PDT (7:20 PM EDT).
Investors, analysts, and
Orexigen Investor Contact:Jason Keyes, Chief Financial Officer+1-858- 875-8600 email@example.com
Orexigen Media Contact:Erika HackmannY&R+1-917-538-3375 firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-at-the-2017-bank-of-america-merrill-lynch-healthcare-conference-300450044.html
SOURCE Orexigen Therapeutics, Inc.
Subscribe to our Free Newsletters!
HELLP syndrome is a rare but serious complication that affects pregnant women. If detected on time, ...
Discectomy is a surgical procedure in which a herniated (bulged) disc that compresses the nerves of ...
Parotidectomy is a surgery to remove a part of or the entire parotid salivary gland, on the side of ...View All